BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Oncology

Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia

Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina's hig...

January 25, 2022 | News

Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer

Analysis of 1,000+ patients, with 12 months mean follow up, demonstrates clinical utility of Signatera for informing post-surgical treatment decisions &nb...

January 24, 2022 | News

Taiwan FDA Has Accepted New Drug Application for Sacituzumab Govitecan

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tra...

January 04, 2022 | News

First Approval in Japan for the KEYTRUDA Plus LENVIMA Combination

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the Japanese Ministry of Health, Labour and Welfare (M...

December 29, 2021 | News

Regor Therapeutics announced authorization from the USFDA to proceed with Regor's Phase 1 clinical development plans for RGT-419B.

On December 23, Regor Therapeutics, a clinical-stage biotech company, announced authorization from the US Food and Drug Administration ...

December 28, 2021 | News

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developin...

December 20, 2021 | News

"We are thinking about new ways for the HCPs to engage with their patients that will be integrated with existing healthcare IT systems" : Dr Richard Banbury

What could be the impact of new COVID-19 variants on global oncology services? This pandemic has disrupted the spectrum of oncology care and poses...

December 17, 2021 | Opinion

Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia

Volition's global strategy is to implement similar agreements with multiple companies to ensure the broadest possible accessibility to the Nu.Q® ...

December 17, 2021 | News

Everest Medicines to treat Triple-Negative Breast Cancer in South Korea

Everest Medicines Limited (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing tran...

December 15, 2021 | News

Clarity and Cardinal Health to address the growing needs in oncology

Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growin...

December 03, 2021 | News

World-first lung cancer screening facility increases chance of cure

The truck will be fitted with the latest technology, integrating imaging, breath and blood biomarker screening, as part of a $2 million Australian Can...

December 01, 2021 | Influencers

Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech

The preclinical research also demonstrated Zantrene's ability to synergise with existing anthracyclines to better kill breast cancer cells. Due to signi...

November 22, 2021 | News

Carina Biotech and CellVec advances clinical trials, making strides for colorectal cancer treatment

Singapore-based viral vector CDMO supplies lentiviruses to Carina Biotech, advancing first in-human clinical trial for bowel cancer treatment ...

November 10, 2021 | News

Veracyte Announces Immunoscore Colon Cancer Test

Veracyte, Inc. today announced that its Immunoscore Colon Cancer test has been included in the Pan-Asian adapted ESMO1 Clinical Practice Guideli...

November 08, 2021 | News

Stay Connected